We had several financings that didnt make the 11/14 edition of Vital Signs.
VectorY Therapeutics – a biotech company developing antibody therapies to treat neurodegenerative diseases, raised a $138M Series A. (Amsterdam, Netherlands)
Needed – a company that develops nutrition products for prenatal care, raised $14M. (LA, CA)
VectorY Therapeutics – a biotech company developing antibody therapies to treat neurodegenerative diseases, raised a $138M Series A. (Amsterdam, Netherlands)
Needed – a company that develops nutrition products for prenatal care, raised $14M. (LA, CA)